Great post smach.
The only thing I would differ on
Great post smach.
The only thing I would differ on is....I think the board will still have a place to discuss our current value vs expected or future value.
I've said before I can't wait till the day we are discussing if we should be trading at $5 or $10 and all the worry about getting curent is behind us.
It's still hard to believe something Doc has worked on for 20 years is taking till the last few weeks of a hard deadline to get done.
Hopefully it gets done and is worth the wait and worry. I'm one of those who has a very significant amount of money invested because of Doc's public statements. It's hard to believe he'd say what he has and fail. The consequences I think would be substantial.
5
1
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Azitra Receives Notice from NYSE American Azitra, Inc. (NYSE American: AZTR), a company on the cutting edge of biopharmaceutical development, is excited to announce that it has received a positive response regarding its listing compliance plan from NYSE American LLC. This news signals a pivotal moment for Azitra as it seeks to ensure its shares remain listed on the...
Continue Reading
NexPoint Real Estate Finance, Inc. Declares Quarterly Dividend DALLAS — NexPoint Real Estate Finance, Inc. (NYSE: NREF) has recently made an announcement regarding its financial decisions, specifically the declaration of a regular quarterly dividend. After thorough deliberation, the board of directors has approved a dividend of $0.50 per share for holders of NREF common...
Continue Reading
Biomea Fusion's Ambitious Public Offering Biomea Fusion, Inc. (NASDAQ: BMEA), a company dedicated to tackling diabetes and obesity through innovative therapies, has taken significant steps towards expanding its operations. The firm is poised to launch an underwritten public offering comprising shares of its common stock along with warrants that enable the purchase of...
Continue Reading
Market Insights on Devon Energy's Recent Options Activity Financial giants have made notable bearish moves recently regarding Devon Energy (NASDAQ: DVN). An in-depth analysis of the options history reveals a total of 12 unusual trades, indicating strong market sentiments. Diving deeper into these trades, it's noteworthy that only 33% of traders are bullish, while a...
Continue Reading
Strong Financial Performance from Citigroup Citigroup Inc. (NYSE: C) showcased impressive financial results for the third quarter of 2024, reporting a net income of $3.2 billion, which translates to earnings per share (EPS) of $1.51. This marks a 3% year-over-year increase in revenue. The solid performance spans all five business segments, highlighting the bank's...
Continue Reading